Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - GlobeStar Therapeutics CorpFinancial_Report.xls
EX-31 - RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION - GlobeStar Therapeutics Corpex_31-1.htm
EX-31 - RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION - GlobeStar Therapeutics Corpex_31-2.htm
10-Q - FORM 10-Q QUARTERLY REPORT FOR 03-31-2012 - GlobeStar Therapeutics Corpform_10-q.htm

EXHIBIT 32.1


SECTION 1350 CERTIFICATION


In connection with the quarterly report of First Titan Corp. (the “Company”) on Form 10-Q for the period ended March 31, 2012 as filed with the Securities and Exchange Commission (the “Report”), I, Robert Federowicz, President of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


May 21, 2012

By:

/s/ Robert Federowicz

 

 

Robert Federowicz

 

 

President, Principal Executive Officer,
Principal Financial and Accounting officer


A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.